Antisense and RNAi Therapeutics Market Expected to Witness Robust Growth, Owing to Focused R&D in Rare Diseases Like ATTR Amyloidosis and SMA

A new report from Industry Experts Inc, on "Antisense and RNAi Therapeutics", discloses that the global market for Antisense and RNAi Therapeutics is estimated at US$5.4 billion in 2024 and is anticipated to post a CAGR of 17.8% during the 2024-2030 analysis period and stand at a projected US$14.4 billion by 2030.

The antisense and RNAi therapeutics market growth is primarily driven by advancements in drug delivery technologies, like lipid nanoparticles and conjugate systems, which improve the stability and cellular uptake of RNA-based drugs. Additionally, the increasing occurrence of chronic and genetic diseases, along with the ability of these therapies to target disease-specific genes, has spurred the demand.

The Antisense RNA segment is the largest market, with an estimated share of 64.1% in 2024, driven by its application in cardiovascular, respiratory, neurodegenerative, and genetic disorders.  Its precision in regulating gene and protein expression enhances therapies and spurs ongoing research. Successful clinical trials and FDA approvals validate antisense therapies' efficacy, attracting investment and increasing demand due to the rising prevalence of these disorders.

Antisense and RNAi Therapeutics market is analyzed in this report globally, covering the major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, the United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The global market for Antisense and RNAi Therapeutics studied in this report with respect to Technology – Antisense RNA and RNA Interference; Route of Administration – Intrathecal, Intravenous, Subcutaneous and Others (Including Topical, Pulmonary, Transdermal, Oral, and Ophthalmic Administration); and Application – Neurodegenerative Disorders, Oncology, Cardiometabolic & Renal Disorders, Genetic Disorders, Infectious Diseases, Respiratory Disorders and Other Applications (Including Ocular, Muscle, Skin, Autoimmune, Hematological Disorders, and Others).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/